| For: | Hvas CL, Ott P, Paine P, Lal S, Jørgensen SP, Dahlerup JF. Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature. World J Gastroenterol 2018; 24(21): 2320-2326 [PMID: 29881241 DOI: 10.3748/wjg.v24.i21.2320] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i21/2320.htm |
| Number | Citing Articles |
| 1 |
R. Yu. Hrytsko, O. M. Bochar, V. T. Bochar. СУЧАСНІ ПОГЛЯДИ НА ХОЛОГЕННУ ДІАРЕЮ. Інфекційні хвороби 2019; (3) doi: 10.11603/1681-2727.2019.3.10635
|
| 2 |
|
| 3 |
Julian R. F. Walters, Rafid Sikafi. Managing bile acid diarrhea: aspects of contention. Expert Review of Gastroenterology & Hepatology 2024; 18(9) doi: 10.1080/17474124.2024.2402353
|
| 4 |
Zenta Yasukawa, Ryo Inoue, Makoto Ozeki, Tsutomu Okubo, Tomohisa Takagi, Akira Honda, Yuji Naito. Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial. Nutrients 2019; 11(9) doi: 10.3390/nu11092170
|
| 5 |
Monjur Ahmed. Functional, Diagnostic and Therapeutic Aspects of Bile. Clinical and Experimental Gastroenterology 2022; doi: 10.2147/CEG.S360563
|
| 6 |
James Morgan, Ashley Bond, Cecil Kullu, Sreedhar Subramanian, Martyn Dibb, Philip J Smith. Managing intestinal failure in inflammatory bowel disease - ‘when the drugs don’t work’. Frontline Gastroenterology 2021; 12(5) doi: 10.1136/flgastro-2018-101058
|
| 7 |
Federica Di Vincenzo, Pierluigi Puca, Loris Riccardo Lopetuso, Valentina Petito, Letizia Masi, Bianca Bartocci, Marco Murgiano, Margherita De Felice, Lorenzo Petronio, Antonio Gasbarrini, Franco Scaldaferri. Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis. Nutrients 2022; 14(13) doi: 10.3390/nu14132664
|
| 8 |
John Y. L. Chiang, Jessica M. Ferrell. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(3) doi: 10.1152/ajpgi.00223.2019
|
| 9 |
. 2024; doi: 10.70675/3d60157fz88efz4edazb51ezd427f44ecb7f
|
| 10 |
Eduard Brunet-Mas, Andrea Peña-Rosado, Belen Garcia-Sagué, Luis Enrique Frisancho, Luigi Melcarne, Laura Patricia Llovet, Anna Puy, Maria José Ramírez-Lázaro, Antonio Rodriguez Revuelto, Alberto Villoria, Xavier Calvet, Sergio Lario. Real-world management of SeHCAT-confirmed bile acid diarrhoea: response to colestyramine and predictors of treatment success. Gastroenterology Report 2026; 14 doi: 10.1093/gastro/goag090
|
| 11 |
Julian R. F. Walters. Letter: long‐term treatment of severe bile acid diarrhoea—obeticholic acid can normalise SeHCAT retention. Alimentary Pharmacology & Therapeutics 2018; 48(9) doi: 10.1111/apt.14979
|
| 12 |
Christian Borup, Lars Vinter‐Jensen, Søren Peter German Jørgensen, Signe Wildt, Jesper Graff, Tine Gregersen, Anna Zaremba, Trine Borup Andersen, Camilla Nøjgaard, Hans Bording Timm, Antonin Lamazière, Dominique Rainteau, Svend Høime Hansen, Jüri Johannes Rumessen, Lars Kristian Munck. Prospective comparison of diagnostic tests for bile acid diarrhoea. Alimentary Pharmacology & Therapeutics 2024; 59(1) doi: 10.1111/apt.17739
|